The provider should ask about weight history, diabetes history, cardiovascular history, kidney concerns, digestive symptoms, thyroid history, prior weight-loss attempts, pregnancy plans (where relevant), and current medications
L-,
Hypoglycemia (very low blood sugar) is more common in people using weight loss injections alongside other antidiabetic medications, such as insulin or sulfonylureas
Thyroid Globulin Antibodies: Ideally, these should be less than 1 for a healthy state
Lilly's phase 3 TRANSCEND-T2D-1 trial of retatrutide showed that the drug reduced A1c levels between 1.7% and 2.0%, depending on the dose, with weight loss as a percentage of starting body weight ranging between 11.5% and 16.8% after 40 weeks of treatment
Beyond appetite regulation, incretin mimetics influence glucose metabolism by enhancing insulin secretion in a glucose-dependent manner and suppressing glucagon release when blood glucose levels are elevated